A New Option for Catheter Guidance Control and Imaging: Interview with Jose L. Merino, MD, PhD, FESC
- Tue, 1/4/11 - 5:55pm
- 0 Comments
- 1658 reads
In this interview we speak with Dr. Jose Merino about Magnetecs Corporation's Catheter
Guidance Control and Imaging (CGCI) system. Dr. Merino is the Director of the Arrhythmia & Electrophysiology Research Unit of Hospital General Universitario La Paz in Madrid, Spain.
Tell us about Magnetecs Corporation's Catheter Guidance Control and Imaging (CGCI) system for patients with arrhythmia. What are the components of this system?
A Life’s Work in Electrophysiology: An Interview with Blair P. Grubb, MD
- Wed, 9/23/09 - 3:48pm
- 3 Comments
- 4433 reads
Dr. Blair Grubb is the Director of Electro-physiology Services at The University of Toledo Medical Center in Ohio. In this special feature, we talk with Dr. Grubb about his career in EP.
You’ve been writing about your experiences with patients for some time now in the Musings section of PACE. What patient has had the most profound effect on you thus far? Tell us about that patient.
Advice on Preventing Device Implant Infections: Interview with Narendra K. Kanuru, MD
- Wed, 8/12/09 - 2:08pm
- 0 Comments
- 2081 reads
Narendra K. Kanuru, MD is an electrophysiologist with Kennestone Hospital in Marietta, Georgia. In this interview with EP Lab Digest, he discusses his methods for preventing and managing possible device implant infections.
How many cardiac rhythm management device (CRMD) implants do you perform monthly, on average?
It varies, but I would say it most likely averages between 500-700 implants per year at our institution.
What is the rate, in general, of cardiac device infections or complications? Are there certain patients at higher risk for infection?
The Efficacy of Microvolt T-Wave Alternans Testing and Other Noninvasive Risk Stratification Methods (full title below)
- Thu, 5/28/09 - 11:07am
- 0 Comments
- 4157 reads
The Efficacy of Microvolt T-Wave Alternans Testing and Other Noninvasive Risk Stratification Methods for Identifying Patients at Risk of Sudden Cardiac Death
Michael J. Mirro, MD, Medical Director of the Parkview Health System Clinical Research Center in Fort Wayne, Indiana, describes his use of microvolt t-wave alternans (MTWA) testing and other noninvasive risk stratification methods for identifying patients at risk for sudden cardiac death (SCD).
Explain the different methods currently available for screening, such as left ventricular ejection fraction and MTWA.
Creating an Updated PAD Program in 2009: EP Lab Digest Speaks with Jim Sideras, RN, MSN, MIFireE, CFO, CMO
- Mon, 1/5/09 - 3:11pm
- 0 Comments
- 1231 reads
In this interview, we speak with Jim Sideras, RN, MSN, MIFireE, CFO, CMO. As the division chief for the Sioux Falls Fire Rescue, he provides us with helpful tips on creating an updated public access defibrillation (PAD) program.
Tell us about your medical background. What job position do you currently hold?
Opening the Bethesda Heart Institute: Challenges and Goals
- Thu, 10/30/08 - 3:27pm
- 0 Comments
- 2471 reads
The Bethesda Heart Institute opened on February 4, 2008, adding an entire cardiovascular service line to Bethesda Memorial Hospital. This article from Cath Lab Digest features an interview with Barbara J. Dale, Executive Director, and Tracy Justice, Assistant Nurse Manager of the Cath/EP lab at Bethesda Heart Institute in Boynton Beach, Florida.
Barbara, in addition to your position as executive director of Bethesda Heart Institute (BHI), what other management is in place?
Barbara: Right now BHI has an assistant nurse manager for the admission/recovery area (ARU), and Tracy Justice is the assistant nurse manager for the cath lab and electrophysiology procedures (EP) area. Prior to the opening of the Heart Institute, the hospital did not have open-heart services or an interventional laboratory. Bethesda Memorial Hospital originally had a 300-procedure diagnostic catheterization laboratory (cath lab).





